FATE THERAPEUTICS INC (FATE:NASDAQ)
$2.45 -0.06 (-2.3904%)
Analysed FATE THERAPEUTICS INC (FATE:NASDAQ) News Sources
Fate Therapeutics Showcases Clinical Data for FT836 at the American Society of Cancer Oncology Annual Meeting
01-06-2026
yahoo.com
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
02-06-2026
yahoo.com
Fate Therapeutics Showcases Data from FT819 and FT839 Programs at the European Congress of Rheumatology Annual Meeting
04-06-2026
yahoo.com
H.C. Reiterates “Buy” Rating On Fate Therapeutics (FATE) With $7 PT
10-06-2026
yahoo.com
Fate Therapeutics Appoints Laura Hamill to Board of Directors
15-06-2026
yahoo.com
Fate Therapeutics to Participate in Upcoming Third Quarter 2026 Conferences
01-07-2026
yahoo.com
Fate Therapeutics to Present Preliminary Clinical Data of FT819 Off-the-Shelf CAR T-Cell Product Candidate for Systemic Sclerosis at the ISSCR 2026 Annual Meeting
06-07-2026
yahoo.com
Fate Therapeutics Receives FDA Clearance of Investigational New Drug Application for FT839 Product Candidate
09-07-2026
yahoo.com
Sector Update: Healthcare Stocks Softer Late Afternoon
09-07-2026
yahoo.com
FATE Stock Jumps 6% As FDA Greenlights Moving Cell Therapy To Clinical Trials
09-07-2026
stocktwits.com
What is the current price of FATE THERAPEUTICS INC (FATE:NASDAQ)?
The current price of FATE THERAPEUTICS INC (FATE:NASDAQ) is $2.45.
FATE THERAPEUTICS INC (FATE:NASDAQ) absolute price change since previous trading day?
The absolute price change of FATE THERAPEUTICS INC (FATE:NASDAQ) since the previous trading day is $-0.06.
FATE THERAPEUTICS INC (FATE:NASDAQ) percentage price change since previous trading day?
The percentage price change of FATE THERAPEUTICS INC (FATE:NASDAQ) since the previous trading day is -2.3904%.
What is the most recent average sentiment score for FATE THERAPEUTICS INC (FATE:NASDAQ)?
The most recent average sentiment score for FATE THERAPEUTICS INC (FATE:NASDAQ) is 87 out of 100.
What is the most recent average sentiment for FATE THERAPEUTICS INC (FATE:NASDAQ)?
The most recent sentiment for FATE THERAPEUTICS INC (FATE:NASDAQ) is .
SEC-8K** Filing Available For FATE THERAPEUTICS INC (FATE:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.